摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,6-Di-O-苯甲基-D-葡萄醛 | 145852-76-2

中文名称
3,6-Di-O-苯甲基-D-葡萄醛
中文别名
——
英文名称
3,6-di-O-benzyl-D-glucal
英文别名
1,5-anhydro-3,6-di-O-benzyl-2-deoxy-D-arabino-hex-1-enitol;(2R,3S,4R)-4-phenylmethoxy-2-(phenylmethoxymethyl)-3,4-dihydro-2H-pyran-3-ol
3,6-Di-O-苯甲基-D-葡萄醛化学式
CAS
145852-76-2
化学式
C20H22O4
mdl
——
分子量
326.392
InChiKey
KUSSRSMLTQREOG-AQNXPRMDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    480.5±45.0 °C(Predicted)
  • 密度:
    1.19±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    24
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    47.9
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 安全说明:
    S24/25

SDS

SDS:702c6accec1b768537f11d615e33353a
查看
Name: 3 6-Di-O-benzyl-D-glucal Material Safety Data Sheet
Synonym:
CAS: 145852-76-2
Section 1 - Chemical Product MSDS Name:3 6-Di-O-benzyl-D-glucal Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
145852-76-2 3,6-Di-O-benzyl-D-glucal unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Moisture sensitive.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a tightly closed container. Store in a dry area. Freeze.
Store under argon.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 145852-76-2: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 129 - 134 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C20H22O4
Molecular Weight: 326.39

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, acids.
Incompatibilities with Other Materials:
Strong oxidizing agents, moisture.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Will not occur.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 145852-76-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3,6-Di-O-benzyl-D-glucal - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 145852-76-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 145852-76-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 145852-76-2 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Glycals 和 4-Deoxypentenosides 立体选择性环氧化中的立体电子因素
    摘要:
    糖醛和 4-脱氧戊烯苷 (4-DP) 是具有相似结构和反应性特征的不饱和吡喃糖苷,在与二甲基二环氧乙烷 (DMDO) 环氧化时可以表现出高度的立体选择性。在大多数情况下,糖类及其相应的 4-DP 等排体具有相同的表面选择性,这意味着吡喃取代基在很大程度上负责立体定向效应。完全取代的二氢吡喃遵循“多数规则”,其中环氧化作用指向三个基团中的两个相反的表面。去除一个取代基对环氧化结果有不同的影响,这取决于它的位置以及其余两个基团的相对立体化学。总的来说,我们观察到糖醛和 4-DP 的表面选择性的最大损失是由 C3 氧的去除引起的,紧接着是 C5/异头取代基,至少是 C4/C2 氧。基于极化 π 前沿分子轨道 (PPFMO) 理论的 DFT 计算支持氧取代基在 4-DP 表面选择性中的立体电子作用,但在糖醛的情况下不太清楚。我们得出结论,4-DP 中的异头氧有助于表面选择性的立体电子偏向,而聚糖中的
    DOI:
    10.1021/jo102382r
  • 作为产物:
    描述:
    参考文献:
    名称:
    Glycals 和 4-Deoxypentenosides 立体选择性环氧化中的立体电子因素
    摘要:
    糖醛和 4-脱氧戊烯苷 (4-DP) 是具有相似结构和反应性特征的不饱和吡喃糖苷,在与二甲基二环氧乙烷 (DMDO) 环氧化时可以表现出高度的立体选择性。在大多数情况下,糖类及其相应的 4-DP 等排体具有相同的表面选择性,这意味着吡喃取代基在很大程度上负责立体定向效应。完全取代的二氢吡喃遵循“多数规则”,其中环氧化作用指向三个基团中的两个相反的表面。去除一个取代基对环氧化结果有不同的影响,这取决于它的位置以及其余两个基团的相对立体化学。总的来说,我们观察到糖醛和 4-DP 的表面选择性的最大损失是由 C3 氧的去除引起的,紧接着是 C5/异头取代基,至少是 C4/C2 氧。基于极化 π 前沿分子轨道 (PPFMO) 理论的 DFT 计算支持氧取代基在 4-DP 表面选择性中的立体电子作用,但在糖醛的情况下不太清楚。我们得出结论,4-DP 中的异头氧有助于表面选择性的立体电子偏向,而聚糖中的
    DOI:
    10.1021/jo102382r
点击查看最新优质反应信息

文献信息

  • Oligosaccharide Synthesis with Glycosyl Phosphate and Dithiophosphate Triesters as Glycosylating Agents
    作者:Obadiah J. Plante、Emma R. Palmacci、Rodrigo B. Andrade、Peter H. Seeberger
    DOI:10.1021/ja016227r
    日期:2001.10.1
    Described is an efficient one-pot synthesis of alpha- and beta-glycosyl phosphate and dithiophosphate triesters from glycals via 1,2-anhydrosugars. Glycosyl phosphates function as versatile glycosylating agents for the synthesis of beta-glucosidic, beta-galactosidic, alpha-fucosidic, alpha-mannosidic, beta-glucuronic acid, and beta-glucosamine linkages upon activation with trimethylsilyl trifluoromethanesulfonate
    描述了通过 1,2-脱水糖从糖基中高效地一锅合成α-和β-糖基磷酸酯和二硫代磷酸三酯。糖基磷酸酯用作多功能糖基化剂,用于合成 β-葡糖苷、β-半乳糖苷、α-岩藻糖苷、α-甘露糖苷、β-葡糖醛酸和 β-葡糖胺键,在用三甲基甲硅烷基三氟甲磺酸酯 (TMSOTf) 活化后。除了作为 O-糖基化的有效供体,糖基磷酸酯还可有效制备 S-糖苷和 C-糖苷。此外,还讨论了糖基磷酸酯与甲硅烷基化受体的酸催化偶联。糖基二硫代磷酸酯被合成并且也用作糖基供体。这种替代方法提供了与含有糖基的受体的兼容性,以形成 β-糖苷。为了最大限度地减少保护基团的操作,报告了使用糖基磷酸酯的正交和区域选择性糖基化策略。描述了一种正交糖基化方法,包括在硫糖苷受体存在下激活磷酸糖基供体,以及受体介导的区域选择性糖基化策略。此外,公开了利用α-和β-糖基磷酸酯反应性差异的独特糖基化策略。此处概述的程序为在溶液中组装复杂寡糖以及通过单
  • Synthesis of carbasugar-containing non-glycosidically linked pseudodisaccharides and higher pseudooligosaccharides
    作者:Ian Cumpstey
    DOI:10.1016/j.carres.2009.09.008
    日期:2009.11
    This minireview covers synthetic methods towards carbasugar-containing non-glycosidically linked pseudodisaccharides or higher pseudooligosaccharides. Carbocyclic pyranose mimetics (saturated or unsaturated between C-5 and C-5a) are linked by ether, thioether or amine bridges to carbohydrates or other carbasugars.
    这份简短的综述涵盖了针对含碳水化合物的非糖苷键连接的假二糖或高级假寡糖的合成方法。碳环吡喃糖模拟物(在C-5和C-5a之间饱和或不饱和)通过醚桥,硫醚桥或胺桥连接到碳水化合物或其他Carcarbugars。
  • Synthesis and Use of Glycosyl Phosphates as Glycosyl Donors
    作者:Obadiah J. Plante、Rodrigo B. Andrade、Peter H. Seeberger
    DOI:10.1021/ol9905452
    日期:1999.7.1
    Differentially protected glycosyl phosphates prepared by a straightforward synthesis from glycal precursors are used as powerful glycosyl donors. Activation of beta-glycosyl phosphates by TMSOTf at -78 degrees C achieves the selective formation of beta-glycosidic linkages in excellent yields with complete stereoselectivity. Reaction with thiols results in the conversion of glycosyl phosphates into thioglycosides
    由糖基前体通过直接合成制备的差异保护的糖基磷酸酯用作强大的糖基供体。TMSOTf在-78摄氏度下激活β-糖基磷酸酯,可以以极好的收率和完全的立体选择性选择性地形成β-糖苷键。与硫醇的反应导致糖基磷酸酯以几乎定量的产率转化为硫糖苷。使用糖基磷酸供体和硫代乙基糖苷受体的正交偶联策略允许快速合成三糖。
  • Linear Synthesis of a Protected H-Type II Pentasaccharide Using Glycosyl Phosphate Building Blocks
    作者:Kerry Routenberg Love、Rodrigo B. Andrade、Peter H. Seeberger
    DOI:10.1021/jo015987h
    日期:2001.11.1
    a variety of nitrogen protecting groups to ensure good glucosamine donor reactivity and protecting group compatibility. The challenge to differentiate C2 of the terminal galactose in the presence of other hydroxyl and amine protecting groups prompted us to introduce the 2-(azidomethyl)benzoyl group as a novel mode of protection for carbohydrate synthesis. The compatibility of this group with traditionally
    报道了利用糖基磷酸酯和糖基三氯乙酰亚氨酸酯结构单元线性合成完全受保护的H型II血型决定子五糖。设想了血型决定簇的自动固相合成,已证明糖基磷酸酯在逐步构建复杂的寡糖(例如H型II型抗原)中的效用。中央氨基葡萄糖结构单元的安装要求筛选各种氮保护基,以确保良好的氨基葡萄糖供体反应性和保护基的相容性。在存在其他羟基和胺保护基的情况下,区分末端半乳糖的C2的挑战促使我们引入2-(叠氮甲基)苯甲酰基作为碳水化合物合成的新型保护方式。检查了该基团与传统使用的保护基的相容性,以及其在糖基化中作为C2立体定向基团的用途。2-(叠氮甲基)苯甲酰基的应用以及对糖基供体的系统评价允许五糖的完成,并提供了预期普遍适用于血型决定簇的固相支持体合成的合成策略。
  • Microwave-Assisted Regioselective Benzylation: An Access to Glycal Derivatives with a Free Hydroxyl Group at C4
    作者:Tadeusz Bieg、Katarzyna Kral、Jadwiga Paszkowska、Wiesław Szeja、Ilona Wandzik
    DOI:10.1080/07328303.2012.698438
    日期:2012.9
    D-glucal, D-galactal, and their 6-O-TBDMS derivatives were benzylated in a two-step procedure under microwave conditions. In the first step glycals were converted into dibutylstannylene acetal or tributyltin ether intermediates, which were next alkylated with benzyl bromide in the presence of Bu4NBr. In all cases the 4-OH group stayed unsubstituted. Microwave-assisted benzylation contributes to a significant
    在微波条件下,分两步将D-葡萄糖,D-半乳糖及其6-O-TBDMS衍生物苄基化。在第一步中,将糖基转化为二丁基亚锡乙缩醛或三丁基锡醚中间体,然后将其在Bu 4 NBr存在下用苄基溴烷基化。在所有情况下,4-OH基团都保持未取代的状态。与传统的合成方法相比,微波辅助的苄基化反应大大减少了反应时间,传统的合成方法需要加热数小时。补充材料可用于本文。转到出版商的《碳水化合物化学杂志》在线版本以查看免费的补充文件。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐